meganuclease

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – French firm Cellectis and North Carolina-based Precision Biosciences have filed two new suits against each other alleging infringement of US patents covering modified meganucleases.

Helix will promote Cellectis' Genome Positioning System line of products and services in India.

The French firm gains access to Cyto Pulse's electroporation technologies and equipment.

Cedarlane will distribute Cellectis Bioresearch's kits in Canada.

The patent has been the subject of ongoing litigation between the French and US biotech firms.

The agricultural products company will use Cellectis' meganuclease tools and will invest in the French firm.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.